Certified by Founder Lodge
Myeloid Therapeutics
United States - Cambridge, Massachusetts
START UP
1 Disclosed Funding Rounds $73,000,000
0 Participating Investments
-
Founded date
2019
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
At Myeloid, we have applied our extensive knowledge of advanced gene and cell therapies to build novel platform technologies that harness the innate abilities of myeloid cells. We have transl
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| May, 19 ,2023 | Unknown | $73,000,000 |
Hatteras Venture Partners
ARCH Venture Partners
Newpath Partners
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
Helex | $3,500,000 | (Nov 4, 2025)
xMEMS | $21,000,000 | (Nov 4, 2025)
catalyx space | $5,400,000 | (Nov 4, 2025)
Cephia AI | $4,000,000 | (Nov 4, 2025)
Ornn | $5,700,000 | (Nov 4, 2025)
